槲皮素PVP固体分散体的制备及物相鉴定

摘要/Abstract

摘要：

目的用溶剂法制备槲皮素-PVP固体分散体并考察其溶出特性并对物相进行鉴定。方法采用溶剂法制备槲皮素-PVP固体分散体,通过溶出实验对槲皮素溶出率的测定研究固体分散体的溶出性质, 利用差热分析(Differentialscanning calorimetry, DSC)、红外光谱分析(Infrared spectroscopy, IR)、粉末X衍射(X-ray powder diffractometry, PXRD)、扫描电镜(Scanning electron microscopy, SEM)等方法对其进行物相鉴定。结果槲皮素-PVP固体分散体的溶出速率相对其物理混合物有了明显的改善; 溶解实验显示固体分散体中槲皮素的溶解度有了显著的提高; 热差分析及粉末X衍射结果表明固体分散体中槲皮素呈非结晶形式; 扫描电镜下固体分散体中无槲皮素晶体。结论采用溶剂法制备槲皮素-PVP固体分散体可显著提高槲皮素的溶解度及溶出速度。

关键词: 槲皮素, 槲皮素, 槲皮素, PVP, PVP, PVP, 固体分散体, 固体分散体, 固体分散体, 溶出率, 溶出率, 溶出率

Abstract: Aim The objective of this study was to prepare and characterize quercetin-polyvinylpyrrolidone (Qurc-PVP) solid dispersion with the intention of improving its dissolution properties. Methods Qurc-PVP solid dispersion was prepared by solvent method. The release rate of quercetin was determined from dissolution studies and the physicochemical properties of solid dispersion were investigated by differential scanning calorimetry (DSC), infrared spectroscopy (IR), powder X-ray diffraction (PXRD) and scanning electron microscopy (SEM). Results The results showed that the dissolution rate of quercetin was significantly improved by solid dispersion compared to that of the pure drug and physical mixture. Solubility studies revealed a markedly increase in the solubility of quercetin. The results of DSC and PXRD showed that the quercetin in solid dispersion was amorphous form. From SEM analysis, there was no quercetin crystal observed in the solid dispersions. Conclusion The solubility and dissolution of quercetin were improved by solid dispersion technique.

Key words: Quercetin, Quercetin, Polyvinylpyrrolidone PVP, Polyvinylpyrrolidone PVP, Solid dispersion, Solid dispersion, Dissolution rate, Dissolution rate

中图分类号:

Supporting:

^*Corresponding author. Tel.: 86-10-82802683; fax: 86-10-82802791

朱静, 杨照罡, 陈晓梅, 孙葭北, 古丽斯坦·阿吾提, 张烜^*, 张强. 槲皮素PVP固体分散体的制备及物相鉴定[J]. .

Jing Zhu, Zhao-GangYang, Xiao-Mei Chen, Jia-Bei Sun, Gulisitan Awuti, Xuan Zhang^*, Qiang Zhang. Preparation and physicochemical characterization of solid dispersion of quercetin and polyvinylpyrrolidone[J]. .

参考文献

[1] Singh A, Naidu PS, Kulkarni SK. Quercetin, a bioflavonoid, reverses develop ment of tolerance and dependence to morphine [J]. Drug Dev Res, 2002, 57 (4): 167–172.
[2] Mahesh T, Menon VP. Quercetin allievates oxidative stress in streptozotocin-induced diabetic rats [J]. Phytother Res, 2004, 18 (2): 123–127.
[3] Pralhad T, Rajendrakumar K. Study of freeze-dried quercetin cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis [J]. J Pharm Biomed, 2004, 34 (2): 333–339.
[4] Sanders RA, Rauscher FM, Watkins JB. Effect of quercetin on antioxidant defense in streptozotocin-induced diabetic rats [J]. J Biochem Mol Toxicol, 2001, 15 (3): 143–149.
[5] Nagasaka YJ, Fijirnoto M, Arai H, et al. Inhibition of heatinduced phosphorylation of stathmin by the bioflavonoid quercetin [J]. Electrophoresis, 2002, 23 (4): 670–673.
[6] Ren WY, Qiao ZH, Wang HW, et al. Flavonoids: promising anticancer agents [J]. Med Res Rev, 2003, 23 (4): 519–534.
[7] Kosmider B, Osiecka R. Flavonoid compounds: a review of anticancer properties and interactions with cis-diamminedichloroplatinum [J]. Drug Dev Res, 2004, 63 (4): 200–201.
[8] Wang YH, Chao PL, Hsiu SL, et al. Lethal quercetin-digoxin interaction in pigs [J]. Life Sci, 2004, 74 (10): 1191–1197.
[9] Hsiu SL, Hou YC, Wang YH, et al. Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats [J]. Life Sci, 2002, 72 (3): 227–235.
[10] Labib S, Erb A, Kraus M, et al. The pig caecum model: A suitable tool to study the intestinal metabolism of flavonoids [J]. Mol Nutr Food Res, 2004, 48 (4): 326–332.
[11] Gee JM, Wroblewska MA, Bennett RN, et al. Absorption and twenty-four-hour metabolism time-course of quercetin-3-O-glucoside in rats, in vivo [J]. Sci Food Agr, 2004, 84 (11): 1341–1348.
[12] Sheen PC, Khetarpal VK, Cariola CM, et al. Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability [J]. Int J Pharm, 1995, 118 (2): 221–227.
[13] Betageri GV, Makarla KR. Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques [J]. Int J Pharm, 1995, 126 (2): 155–160.
[14] Arias MJ, Gines JM, Moyano JR, et al. Influence of the preparation method of solid dispersions on their dissolution rate: study of triameterene-D-mannitol system [J]. Int J Pharm, 1995, 123 (1): 25–31.
[15] Okonogi S, Oguchi T, Yonemochi E, et al. Improved dissolution of ofloxacin via solid dispersion [J]. Int J Pharm, 1997, 156 (2): 175–180.
[16] Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions [J]. Eur J Pharm Biopharm, 2000, 50 (1): 47–60.
[17] Verheyen S, Blaton N, Kinget R, et al. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions [J]. Int J Pharm, 2002, 249 (1): 45–58.
[18] Weuts I, Kempen D, Decorte A, et al. Phase behavior analysis of solid dispersions of loperamide and two structurally related compounds with the polymers PVP-K30 and PVP-VA64 [J]. Eur J Pharm Sci, 2004, 22 (5): 375–385.
[19] Marin MT, Margarit MV, Salcedo GE. Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone [J]. II Farmaco, 2002, 57 (9): 723–727.
[20] Mooter GV, Augustijns P, Blaton N, et al. Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30 [J]. Int J Pharm, 1998, 164 (1): 67–80.
[21] Gubskaya. Effect of grinding on physic-chemical properties of drugs. Part 1. Theophylline: evaluation of particle sizes and degree of crystallinity, relation to dissolution parameters [J]. Drug Dev Ind Pharm, 1995, 21: 1953–1964.
[22] Villiers MM, Wurster DE, Vanderwatt JG, et al. X-Ray powder diffraction determination of the relative amount of crystalline acetaminophen in solid dispersions with polyvinylpyrrolidone [J]. Int J Pharm, 1998, 163 (2): 219–224.